Purchase Order SPE2DP24P0308

Award Date 3/7/24
Potential Completion Date 3/12/24
Potential Value $3.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
<p>Fenwal, Inc. has been awarded a purchase order contract by the Defense Logistics Agency Troop Support Medical for $1,810.80 to deliver diluting solution. The contract has a firm fixed price and period of performance through November 17, 2023. No set aside designation was applied. As a global blood technology company and manufacturer, Fenwal will likely supply the requested medical solution to support the agency's provision of supplies to military treatment facilities.</p>
This firm fixed-price purchase order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,188.92 contract is for the supply of washing solution, FR (flame retardant) to support federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. Fenwal has a long history of providing a wide range of medical supplies and...
The U.S. Defense Logistics Agency awarded a $2,188.92 firm fixed-price purchase order to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the supply of &quot;Washing Solution, FR&quot; to support the agency's medical supply chain operations. This award does not have a set-aside designation. Fenwal has extensive experience providing a wide range of medical supplies and equipment, including blood bags, tubing, solutions, and specialized items,...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $1,287.60 firm fixed price purchase order is for the delivery of &quot;Washing Solution, FR&quot; and has a completion date of March 4, 2024. Fenwal, a manufacturer of blood collection, separation, storage, and transfusion products, has received numerous prior contract awards from federal agencies including the...
This federal contract award, valued at $1,839.04, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of blood packs with anticoagulant (8510030842) and has a completion date of August 14, 2023. Fenwal, a registered federal vendor since 2007, has a strong track record of supporting the U.S. government's healthcare and research initiatives by providing a diverse array...
The U.S. government awarded a firm-fixed-price purchase order to Fenwal, Inc., a Fresenius Kabi company, to provide &quot;Washing Solution, FR&quot; under contract number SPE2DP24P0374. The contract has an ultimate completion date of March 27, 2024 and a ceiling value of $1,287.60. Fenwal, Inc. is a global blood technology company that has an extensive history of providing blood collection, separation, storage, and transfusion products and services to various federal agencies, including the...
This federal contract award, valued at $1,931.40, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the provision of medical supplies, including 0.2% dextrose and 0.9% sodium chloride solutions, to support various government agencies. Fenwal, a registered federal vendor since 2007, has a long history of supplying a wide range of transfusion medicine and cell therapy products to...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price purchase order contract worth $3,378.50 to Fenwal, Inc., a subsidiary of Fresenius Kabi, to provide 8510943569 ! WASHING SOLUTION,FR. This contract has an ultimate completion date of October 15, 2024 and was awarded on October 9, 2024. Fenwal, Inc. is a global blood technology company that has established itself as a key supplier to various federal agencies, primarily supporting transfusion medicine and cell...
This federal contract award, valued at $1,426.36, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various medical supplies and equipment, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The contract does not have a set-aside designation, reflecting Fenwal's...

The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price purchase order to Fenwal, Inc., a Fresenius Kabi company, for the delivery of Diluting Solution, F. The $3,621.60 contract has a completion date of March 12, 2024. Fenwal, Inc. is a global blood technology company that has an extensive history of providing blood collection, separation, storage, and transfusion products and services to various federal agencies. The company has supported the U.S. military's frozen blood program and has supplied consumables, cell processing kits, separators, and service agreements to facilitate biomedical research and blood banking operations for the federal government. This contract was awarded without a set-aside designation due to Fenwal's unique capabilities as a manufacturer and provider of specialized transfusion medicine and cell therapy products.

Generated 6/6/24, 9:08 AM